Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Daniel Gutmann

Clifford Chance
Claim this profile
Firm
Clifford Chance
Practice
Corporate, Corporate/Private Equity
Office
Frankfurt, Frankfurt/Düsseldorf
Active in the record
2020 to 2022

Deal experience

Deal types
Capital Markets & IPOM&A
Sectors
Consumer & RetailHealthcare & Life Sciences
Jurisdictions
AustriaBelgiumFranceGermanySpainUnited KingdomUnited States

Deals

5 announced deals in the record
Clifford Chance advises Cinven on USD 2.6bn-acquisition of Bayer Environmental Science Professional 11 Mar 2022
M&A Healthcare & Life Sciences Clifford Chance USD 2.60bn Corporate/Private Equity
Clifford Chance advises investors’ consortium comprising OMERS, Goldman Sachs and AXA on acquisition of leading laboratory services provider amedes 3 Aug 2021
M&A Healthcare & Life Sciences Clifford Chance Corporate Frankfurt/Düsseldorf
Clifford Chance advises SYNLAB and majority shareholders Cinven, Novo Holdings and OTPP on IPO and initial listing at Frankfurt Stock Exchange 7 May 2021
Capital Markets & IPO Healthcare & Life Sciences Clifford Chance EUR 772m Corporate Frankfurt
Clifford Chance advises Triton on the acquisition of SCHOCK 18 Feb 2021
M&A Consumer & Retail Clifford Chance Corporate/Private Equity Frankfurt
Clifford Chance advises Permira on the acquisition of Neuraxpharm 23 Sept 2020
M&A Healthcare & Life Sciences Clifford Chance Corporate/Private Equity Frankfurt
Pro

Analytics for Daniel Gutmann

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction